Israili ZH. Advances in the treatment of type 2 diabetes mellitus. Am J Ther. 2011;18(2):117–52.

Article  PubMed  Google Scholar 

Wu Y, Zhou A, Tang L, et al. Bile acids: key regulators and novel treatment targets for type 2 diabetes. J Diabetes Res. 2020;2020:6138438.

Article  PubMed  PubMed Central  Google Scholar 

Mantovani A, Dalbeni A, Peserico D, et al. Plasma bile acid profile in patients with and without type 2 diabetes. Metabolites. 2021;11(7):453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Shi Z, Zhang R, et al. Liver proteomics analysis reveals abnormal metabolism of bile acid and arachidonic acid in Chinese hamsters with type 2 diabetes mellitus. J Proteomics. 2021;239: 104186.

Article  CAS  PubMed  Google Scholar 

Zhang Q, Hu N. Effects of metformin on the gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2020;13:5003–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Catoi AF, Parvu A, Muresan A, et al. Metabolic mechanisms in obesity and type 2 diabetes: insights from bariatric/metabolic surgery. Obes Facts. 2015;8(6):350–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Zhang J, Zhou Z. Targeting Islets: metabolic surgery is more than a bariatric surgery. Obes Surg. 2019;29(9):3001–9.

Article  PubMed  Google Scholar 

Huang HH, Lee WJ, Chen SC, et al. Bile acid and fibroblast growth factor 19 regulation in obese diabetics, and non-alcoholic fatty liver disease after sleeve gastrectomy. J Clin Med. 2019;8(6):815.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu T, Yang M, Xu H, et al. Serum bile acid profiles improve clinical prediction of nonalcoholic fatty liver in T2DM patients. J Proteome Res. 2021;20(8):3814–25.

Article  CAS  PubMed  Google Scholar 

Jin ZL, Liu W. Progress in treatment of type 2 diabetes by bariatric surgery. World J Diabetes. 2021;12(8):1187–99.

Article  PubMed  PubMed Central  Google Scholar 

Staels B, Handelsman Y, Fonseca V. Bile acid sequestrants for lipid and glucose control. Curr Diab Rep. 2010;10(1):70–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albaugh VL, Banan B, Ajouz H, et al. Bile acids and bariatric surgery. Mol Aspects Med. 2017;56:75–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaska L, Sledzinski T, Chomiczewska A, et al. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol. 2016;22(39):8698–719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

di Ciaula A, Garruti G, Lunardi R, et al. Bile acid physiology. Ann Hepatol. 2017;2017(16):S4–14.

Article  Google Scholar 

Browning MG, Pessoa BM, Khoraki J, et al. Changes in Bile acid metabolism, transport, and signaling as central drivers for metabolic improvements after bariatric surgery. Curr Obes Rep. 2019;8(2):175–84.

Article  PubMed  Google Scholar 

Pandak WM, Kakiyama G. The acidic pathway of bile acid synthesis: Not just an alternative pathway(). Liver Res. 2019;3(2):88–98.

Article  PubMed  PubMed Central  Google Scholar 

Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol. 2014;10(8):488–98.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Ning G, Handelsman Y, et al. Gut hormones and the brain. J Diabetes. 2010;2(3):138–45.

Article  CAS  PubMed  Google Scholar 

Rajani C, Jia W. Bile acids and their effects on diabetes. Front Med. 2018;12(6):608–23.

Article  PubMed  Google Scholar 

Tiessen RG, Kennedy CA, Keller BT, et al. Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. BMC Gastroenterol. 2018;18(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Ridlon JM. Bariatric surgery stirs symbionts to counteract diabesity by CA(7)Sting a liver-generated bile acid into the mix. Cell Host Microbe. 2021;29(3):320–2.

Article  CAS  PubMed  Google Scholar 

Ocana-Wilhelmi L, Martin-Nunez GM, Ruiz-Limon P, et al. Gut microbiota metabolism of bile acids could contribute to the bariatric surgery improvements in extreme obesity. Metabolites. 2021;11(11):733.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiang JYL, Ferrell JM. Bile acid metabolism in liver pathobiology. Gene Expr. 2018;18(2):71–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemis JH, Linke V, Barrett KL, et al. Genetic determinants of gut microbiota composition and bile acid profiles in mice. PLoS Genet. 2019;15(8): e1008073.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020;11(2):158–71.

Article  PubMed  Google Scholar 

Zhang F, Yuan W, Wei Y, et al. The alterations of bile acids in rats with high-fat diet/streptozotocin-induced type 2 diabetes and their negative effects on glucose metabolism. Life Sci. 2019;229:80–92.

Article  CAS  PubMed  Google Scholar 

Fouladi F, Mitchell JE, Wonderlich JA, et al. The contributing role of bile acids to metabolic improvements after obesity and metabolic surgery. Obes Surg. 2016;26(10):2492–502.

Article  PubMed  Google Scholar 

Wang M, Wu Q, Xie H, et al. Effects of sleeve gastrectomy on serum 12alpha-hydroxylated bile acids in a diabetic rat model. Obes Surg. 2017;27(11):2912–8.

Article  PubMed  Google Scholar 

Maghsoodi N, Shaw N, Cross GF, et al. Bile acid metabolism is altered in those with insulin resistance after gestational diabetes mellitus. Clin Biochem. 2019;64:12–7.

Article  CAS  PubMed  Google Scholar 

Wang S, Deng Y, Xie X, et al. Plasma bile acid changes in type 2 diabetes correlated with insulin secretion in two-step hyperglycemic clamp. J Diabetes. 2018;10(11):874–85.

Article  CAS  PubMed  Google Scholar 

Zangerolamo L, Vettorazzi JF, Solon C, et al. The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer’s disease mice model. Mol Cell Endocrinol. 2021;521: 111116.

Article  CAS  PubMed  Google Scholar 

Mazidi M, de Caravatto PP, Speakman JR, et al. Mechanisms of action of surgical interventions on weight-related diseases: the potential role of bile acids. Obes Surg. 2017;27(3):826–36.

Article  PubMed  Google Scholar 

Staels B. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus. Postgrad Med. 2009;121(3 Suppl 1):25–30.

Article  PubMed  Google Scholar 

Lee SG, Lee YH, Choi E, et al. Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status. Clin Chem Lab Med. 2019;57(8):1218–28.

Article  CAS  PubMed  Google Scholar 

Bahne E, Sun EWL, Young RL, et al. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight. 2018. https://doi.org/10.1172/jci.insight.93936.

Article  PubMed  PubMed Central  Google Scholar 

Lee G, Park YS, Cho C, et al. Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Metabolomics. 2021;17(8):71.

Article  CAS  PubMed  Google Scholar 

Li M, Hu X, Xu Y, et al. A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models. Int J Endocrinol. 2019;2019:3248527.

Article  PubMed  PubMed Central  Google Scholar 

Garzel B, Hu T, Li L, et al. Metformin disrupts bile acid efflux by repressing bile salt export pump expression. Pharm